Towel Eva Case,Eva Bath Towel Storage Box,Sports Towel Bath Towel Organizer,Eva Sports Towel Storage Bag Dongguan Yuanlai Packaging Products Technology Co., Ltd. , https://www.ylevacase.com
From January to March this year, the import and export of raw material drugs continued the good development momentum of last year. The import and export volume of chemical raw material drugs was 5.735 billion U.S. dollars, an increase of 29.98% year-on-year, accounting for 52.72% of the total import and export volume of medicines and health products during the same period. Among them, the import amount was 1.602 billion U.S. dollars, an increase of 16.89% year-on-year, accounting for 41.6% of the total imports of pharmaceutical and health products, and the export value was 4.133 billion U.S. dollars, an increase of 35.88% year-on-year, accounting for 58.8% of the total medical insurance product exports.
Since 2001, the average annual compound growth rate of China's API exports has exceeded 20%. The role of exports in the API industry is increasingly evident. According to the analysis of the China Chamber of Commerce for the Import and Export of Medicines and Health Products, the raw material medicine exports in the first quarter showed the following characteristics:
First, the general trade ratio is significant, and the processing price of imported materials is high. The export trade of raw materials in China is dominated by general trade with a proportion of 86.7%, and the average export price from January to March is generally the largest increase, which is 49%; the increase in feed processing trade is followed by 30%; the increase in processing The smallest, only 6%.
Second, the traditional export market is still distributed, and export growth is generally larger. Asia, Europe and North America are the traditional export markets for raw materials in China. The three major markets accounted for 88.9% of the total market for APIs, and the Asian market took the lead with 41.3%. From January to March, the volume of raw material medicines exported to China's three major markets rose and the export value increased by more than 40%. The United States, India, Germany, Japan, and the Netherlands are the top five exporters of raw material medicines in China. The export volume of raw material medicines to the five countries ranges from 5.44% to 13.95%. Although except India, China’s exports to the other four countries have declined in different degrees in the first three months, due to the general increase in export prices by more than 35%, the final export value has also increased in varying degrees. From January to March, China’s exports to Iraq, Tajikistan, and Latvia increased significantly, reflecting the positive results of the diversification of the API market.
Third, local enterprises are the first to export. From January to March, a total of 5,015 companies exported APIs to the international market, Zhejiang Xinhecheng Co., Ltd., Zhejiang Medicines and Health Products Import & Export Co., Ltd., Zhejiang Pharmaceutical Co., Ltd., Northeast Pharmaceutical Factory, and Weisheng Pharmaceutical. Five companies such as (Shijiazhuang) Co., Ltd. ranked among the top 5 in terms of export value, and the export volume of these five companies accounted for more than 1% of the total export volume of raw material medicines, and the export growth rate was between 337% and 196%.
Fourth, the market supply and demand are expected to be tight, and export prices have risen sharply. Due to the implementation of new environmental emission standards for pharmaceutical companies this year and concerns about the production restrictions imposed by the Beijing Olympic Games on high-polluting enterprises in surrounding areas, the industry generally believes that the market supply of APIs will be tight this year, coupled with the appreciation of the renminbi and the decline in export tax rebates. The increase in the prices of raw materials such as grain and foodstuffs and the increase in the cost of employment caused by the implementation of the new labor contract law pushed the export prices of APIs from January to March to go up all the way, causing a significant increase. The average price of general trade exports rose by 49%. Among bulk bulk drugs, the average price of saccharine exports increased by 226.61% year-on-year, the average price of vitamin C exports rose by 99.57%, and the average price of paracetamol exports increased by 15.28%. The average export price of some old varieties such as tetracycline and chloramphenicol also increased by more than 46%. Although the export volume of some products and some markets has decreased, the export value has increased in different degrees, and the price increase factor is prominent.
5. The degree of industrial concentration is high, and the advantages of the coastal provinces are obvious. The provinces that rank among the top three exporters of raw materials in China are Jiangsu Province, Zhejiang Province, and Shandong Province. The proportion of raw material medicine exports in the three provinces accounts for 53% of the country’s total exports.
In recent years, China's raw material pharmaceutical industry has developed rapidly, and China has become the world's largest producer and exporter of chemical raw material drugs. Due to the fundamental change in the pattern and needs of the international pharmaceutical market, no other country in the international market for raw material medicines in China has been able to immediately replace it. The price of raw materials in China has been tightened and the international market price has justified this judgment. Due to the significant increase in comprehensive costs and the accelerated development of specialty APIs, it is expected that the export prices of APIs in our country will remain high this year. Although there are many unfavorable factors mentioned above, the export volume may decrease or increase, but due to the large increase in prices, The export amount will maintain the growth momentum. Therefore, it is optimistic that the export growth will exceed 20% this year.
In 2008, China's "raw material exports" is expected to grow by 20%
According to customs statistics, in the first quarter of this year, the export value of China's chemical raw material medicine was 4.133 billion US dollars, an increase of 335.88% year-on-year. The China Chamber of Commerce for the Import and Export of Medicines and Health Products is expected to maintain high export prices for APIs throughout the year, and the annual export volume is expected to increase by 20%.